Receptor gene screening for detecting or diagnosing cancer

作者: David A. Sirbasku

DOI:

关键词:

摘要: Compositions and methods that use the body's natural secretory immune system in a new way against steroid hormone responsive tumors of breast prostate, as well other glandular/mucus epithelial tissues such colon, ovary, endometrium, kidney, bladder, stomach, pancreas pituitary gland are provided. Also provided ways identifying carcinogenic, or potentially bacteria tissue body fluid to provide better anti-cancer therapies preventatives than have been available previously.

参考文章(266)
M. A. South, J. P. Harris, Secretory component: a glandular epithelial cell marker. American Journal of Pathology. ,vol. 105, pp. 47- 53 ,(1981)
Hans L. Spiegelberg, Biological activities of immunoglobulins of different classes and subclasses. Advances in Immunology. ,vol. 19, pp. 259- 294 ,(1974) , 10.1016/S0065-2776(08)60254-0
Toshiaki Kawai, Chikao Torikata, Minoru Suzuki, Immunohistochemical study of pulmonary adenocarcinoma. American Journal of Clinical Pathology. ,vol. 89, pp. 455- 462 ,(1988) , 10.1093/AJCP/89.4.455
David O. Carpenter, Masao Tanji, A steroid-binding protein mediates estrogen-dependent inhibition of growth of MCF-7 breast cancer cells. Anticancer Research. ,vol. 20, pp. 2785- 2789 ,(2000)
Barbara C. Spink, David O. Carpenter, Barbara H. Katz, Masao Tanji, Growth inhibition of MCF-7 cells by estrogen is dependent upon a serum factor. Anticancer Research. ,vol. 20, pp. 2779- 2783 ,(2000)
Detlef Piechaczek, Wolfgang Stephan, Dieter Rudnick, Ronald Kotitschke, Wolfgang Moller, Process for the preparation of a pharmaceutical which contains igg, iga and igm and can be administered intravenously ,(1990)